Pramipexole Conversion to Ropinirole Controlled Release (CR)
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
A conversion study of Mirapex (pramipexole) to Requip (ropinirole) controlled release (CR) in
patients with Parkinson's disease to determine the appropriate conversion ratio and side
effects related to the drug.